Amgen to Purchase Drugmaker Horizon Theraputics
Amgen has agreed to purchase drugmaker Horizon Theraputics. The deal is valued at $27.8 billion.
Just the facts news and no spin!
Just the facts news and no spin!
Amgen has agreed to purchase drugmaker Horizon Theraputics. The deal is valued at $27.8 billion.